Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
2 participants
INTERVENTIONAL
2023-10-31
2023-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Mixing Alcoholic Drinks Make Hangover Worse?
NCT03506516
Alcoholic Liver Disease and the Gut Microbiome
NCT05007470
Moderate Alcohol Consumption, Glucose Metabolism and Gastric Emptying
NCT00523861
Alcohol and Innate Immunity
NCT02568904
The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning
NCT05946083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Before the start of the intervention, the test subjects will be instructed to eat the same diet during the 48 hours before beginning of each intervention. The subjects will keep a food diary for two days in order to accurately evaluated the nutritional status. The key is that both subjects consume the same food in both times before the intervention. The food intake itself is determined by the respondents independently.
After the intervention, the respondents will fill out a selection of questionnaires created in the form using the link a special online document (Project BLAM, Forms, Microsoft, USA) that will evaluate theirs alcoholic hangover. In order to evaluate the dynamics of the hangover, the test subject will again every 2 hours fill out the questionnaire (6 evaluations in total - waking up, 2, 4, 6, 8 and 10 hours after waking up). The result of each questionnaire is obtained by calculating the arithmetic mean of all answers (0-5, 0-10). Using all questionnaire was approved by the publisher and the English version will be used. Questionnaires were used https://forms.office.com/Pages/DesignPageV2.aspx subpage=design\&FormId=hN0190t4UESOZ73jM ACw9LJ5ROlYHHVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u\&Token=fcda6871a b5d4009b779536b561d8dfb :
* Alcohol Hangover Questionnaire (AHQ)
* Alcohol Hangover Severity Scale (AHSS)
Materials The subject of the test will be supplementation with a precise probiotic for hangovers (Myrkl, De Fair
Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:
* 560 mg of naturally fermented rice bran
* Bacillus subtilis
* B. coagulans
* L-cysteine
* dextrin
* 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate The CFU per strain in the formulation is minimal (ask the manufacturer). The probiotic comes in capsule form blister, stored at room temperature. An 800 mg capsule containing dextrin (maltodextrin) will be used for the placebo. It's a placebo dose also two capsules of 800 mg each.
The recommended intake will be two capsules exactly two hours before alcohol consumption. Control entry will be through a video diary.
Methods Analyzes of the intestinal microbiome Since the impact of probiotics on the intestinal microbiome will be measured before and after the investigated intervention two analyzes of the intestinal microbiome will be carried out on Day 0, i.e. on the day of the start of the intervention and Day 1, the day after the intervention. The BIOMES sampling kit will be used for the analysis, and intest.pro. The analysis will be performed on a sample of the first morning stool that the test subjects will take independently in home conditions Day 0 and Day 1. Samples will be delivered to the company's laboratory by logistics service BOMES (BIOMES GmbH, Wildau, Germany) where next-generation sequencing of 16s will be performed ribosomal RNA and bioinformatic analysis of the results (review of taxonomy and functionality). These results will be delivered to the researchers.
Statistical analysis Statistical data processing will analyze the changes in both test subjects, B1 and B2, taking taking into account whether the intervention was verum (V) or placebo (P). Upon maturity descriptive and inferential statistics will be made of the results using the appropriate program (Statistica, Palo Alto, USA). For normally distributed data, use the Kolmogorov-Smirnoff test will be the average and standard deviation, and for the second group the median and percentiles. To analyze the hypothesis treatment Mann-Whitney test and paired t-test will be used. Statistically significant will be considered p- values less than 0.05.
The research is divided into three phases - before the intervention, intervention, and after interventions. Alcohol is administered during the intervention. The respondents choose the drink they want consumed in two categories: welcome drink - žestice, brandy, liqueur, wormwood, evening drink - gemišt, wine, beer, gin and tonic, juice and juice.
Before intervention:
* the test subjects took the tests and research material at the Sky Office reception
* 48 hours before the intervention, they monitor their diet through a diary
* both test subjects eat absolutely identical food before each intervention
* on Day 0 they take the first stool sample (test A, test C), ideally the morning stool/the first stool
* do not consume any alcohol
* two hours before the planned intervention, say 6:30 p.m., that means around 4:30 p.m. they take a capsule with 1 dl water
Intervention:
* the subjects come to the recording on Day 0 around 18.00 in the CCM area, the conference room
* from 18.00 to 18.30 is preparation for recording
* at 6:30 p.m. the first sip of alcohol follows - a welcome drink (zestica, liqueur)
* around 6:40 p.m. the drinks of the evening follow (gemišt, gin and tonic, beer, wine)
* the first interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
* around 7:00 p.m., the first cut follows - a welcome drink
* around 7:10 p.m., another drink in the evening
* a second conversation follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
* during the second interview, the interviewees have the opportunity to eat something small (meal/sandwich)
* around 19.10 the last drink of the evening goes, possibly. and a welcome drink
* a third interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
* Human Lab takes a blood sample to determine blood ethanol, which CCM employees will take to HKA KBSD same evening immediately
After the intervention:
* after waking up and then within two hours, the subjects fill out the questionnaire: https://forms.office.com/Pages/ResponsePage.aspx?id=hN0190t4UESOZ73jMACw9LJ5ROlYH HVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u
* the morning stool or the first stool after the intervention should be sampled on Day 1
* on Day 1 around 18.00 arrival for filming at the same place
* from 18.00 to 19.00 a conversation about how they feel and whether they think they received a placebo or a probiotic.
After the end of the cycle and the arrival of the results of the analysis, the researchers enter the data into the for that predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of the statistical analysis in the previously explained manner. In these last steps student, research assistants may be involved.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic
Participants will consume 800 mg of probiotic Myrkl before consuming alcohol in the form of one capsule. (Myrkl, De Fair Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:
* 560 mg of naturally fermented rice bran
* Bacillus subtilis
* B. coagulans
* L-cysteine
* dextrin
* 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate
Myrkl
The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg
Placebo
The subject who consumed 800 mg of placebo- dextrin (maltodextrin) in the form of two capsules before consuming alcohol.
dextrin
The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myrkl
The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg
dextrin
The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inability to drink alcohol
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Gut Microbiome Center (Centar za crijevni mikrobiom)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrija Karačić, dr.med
Role: STUDY_DIRECTOR
Centar za crijevni mikrobiom
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gut Microbiome Center
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study
Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BLAM123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.